Developments in Bone Marrow Transplantation



It is an honour as well a pleasure to participate in this 20th anniversary of the famous round table meetings of Prof Walter Brendel. I have had the privilege of being present at most of these conferences, and this has given me the opportunity to interact with a variety of outstanding scientists. It has also been a source of inspiration and has added to my education. At these meetings we have also been exposed to scores of associates of Walter’s, and over the years we have witnessed their development under his guidance. I have always admired Walter’s aptitude for selecting these researchers, who have contributed so much in achieving the ideal blend of sports, pleasure and serious scientific exchange which have been the outstanding features of these meetings.


Total Body Irradiation Mixed Chimerism Follow Bone Marrow Transplantation Haemopoietic Stem Cell Bone Marrow Graft 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bau J, Tierfelder S (1973) Antilymphocytic antibodies and marrow transplantation. I. Transplantation 15: 564CrossRefGoogle Scholar
  2. 2.
    Burnett AK, Hann IM, Robertson AG, Alcorn M, Gibson B, McVicar I, Niven L, Mackinnon S, Hambley H, Morrison A, Todd A (1988) Prevention of graft-versus-host disease by ex vivo T cell depletion: reduction in graft failure with augmented total body irradiation. Leukemia 2: 300PubMedGoogle Scholar
  3. 3.
    Dicke KA, Van Hooft JIM, Van Bekkum DW (1968) The selective elimination of immunologically competent cells from bone marrow and lymphatic cell mixtures. II. Transplantation 6: 562Google Scholar
  4. 4.
    Fischer A, Griscelli C, Friedrich W, Kubanek B, Levinsky R, Morgan G, Vossen J, Wagemaker G, Landais P (1986) Bone-marrow transplantation for immunodeficiencies and osteopetrosis. European survey (1986). Lancet ii: 1080–1084Google Scholar
  5. 5.
    Hagenbeek A, Löwenberg B (1987) Prevention of graft-versus-host disease without take failures after allogeneic bone marrow transplantation. In: Bone marrow transplantation Vol. 2, Suppl 1, p 141Google Scholar
  6. 6.
    Hobbs JR (1981) Bone marrow transplantation for inborn errors. Lancet ii: 735–739Google Scholar
  7. 7.
    Hoogerbrugge PM, Poorthuis BJHM, Romme AE, Van de Kamp JJP, Wagemaker G, Van Bekkum DW (1988) Effect of bone marrow transplantation on enzyme levels and clinical course in the neurologically affected twitcher mouse. J Clin Invest 81: 1790–1794Google Scholar
  8. 8.
    Hoogerbrugge PM, Suzuki KSK, Poorthuis BJHM, Kobayashi T, Wagemaker G, Van Bekkum DW (1988) Donor-derived cells in the central nervous system of twitcher mice after bone marrow transplantation. Science 239: 1035–1038PubMedCrossRefGoogle Scholar
  9. 9.
    Ichiokaf T, Kishimoto Y, Brennan S, Santos GW, Yeager AM (1987) Hematopoietic cell transplantation in murine globoid cell leukodystrophy (the twitcher mouse): effects on levels of galactosylceramidase, psychosine, and galactocerebrosides. Proc Natl Acad Sci USA 84: 4259–4263CrossRefGoogle Scholar
  10. 10.
    Krivit W, Paul NW (eds) (1986) Bone marrow transplantation for treatment of lysosomal storage diseases. Liss, New YorkGoogle Scholar
  11. 11.
    Löwenberg B, Wagemaker G, Van Bekkum DW, Sizoo W, Sintnicolaas K, Hendriks WDH, Hagenbeek A (1986) Graft-versus-host disease following transplantation of ‘one log’ versus ‘two log’ T-lymphocyte-depleted bone marrow from HLA-identical donors. Bone Marrow Transplant 1: 133PubMedGoogle Scholar
  12. 12.
    Naji A, Silvers WK, Bellgrau D, Bakker CF (1981) Spontaneous diabetes in rats. Science 213:1390— 1392Google Scholar
  13. 13.
    O’Donoghue JA, Wheldon TE, Gregor A (1987) The implications of in-vitro radiation-survival curves for the optimal scheduling of total-body irradiation with bone marrow rescue in the treatment of leukaemia. Br J Radiol 60: 279PubMedCrossRefGoogle Scholar
  14. 14.
    Prentice HG, Blacklock HA, Janossy G, Gilmore MJML, Price-Jones L, Tidman N, Trejdosiewicz LK, Skeggs DBL, Panjwani D, Ball S, Graphakos S, Patterson J, Ivory K, Hoffbrandt AV (1984) Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukaemic marrow transplant recipients. Lancet i: 472–476Google Scholar
  15. 15.
    Schultz FW, Vriesendorp HM, Hagenbeek A (1991) On the quantitative role of graftversus-host disease in decreasing the leukemia relapse rate after allogeneic bone marrow transplantation. (to be published)Google Scholar
  16. 16.
    Van Bekkum DW (1964) The selective elimination of immunological cells from bone marrow and lymphatic cell markers. I. Transplantation 2: 293Google Scholar
  17. 17.
    Van Bekkum DW, Dicke KA (1972) Treatment of immune deficiency disease with bone marrow stem cell concentrates. In: Porter R, Knight J (eds) Ontogeny of acquired immunity. CIBA Foundation Symposium, London, 23–25 Nov 1971, Elsevier, Amsterdam, p 233Google Scholar
  18. 18.
    Van Bekkum DW, Vos 0 (1957) Immunological aspects of homo-and heterologous bone marrow transplantation in irradiated animals. J Cell Comp Physiol 50[suppl 11: 139Google Scholar
  19. 19.
    Van Bekkum DW, Wagemaker G, Vriesendorp HM (1979) Mechanisms and avoidance of graft-versus-host disease. Transplant Proc 11: 189PubMedGoogle Scholar
  20. 20.
    Van Bekkum DW, Kinwel-Bohré EPM, Houben PFJ, Knaan-Shanzer S (1989) Regression of adjuvant-induced arthritis in rats following bone marrow transplantation. Proc Natl Acad Sci USA 86: 1090–1094CrossRefGoogle Scholar
  21. 21.
    Vriesendorp HM (1985) Engraftment of hemopoietic cells. In: Van Bekkum DW (ed) Bone marrow transplantation. Dekker, New York, p 73 (chap 2 )Google Scholar
  22. 22.
    Wagemaker G (1986) Problem and prospects of histocompatible bone marrow transplantation studies in rhesus monkeys. In: Hagenbeek A, Löwenberg B (eds) Minimum residual disease in acute leukemia. Nijhoff, Boston, pp 363–373CrossRefGoogle Scholar
  23. 23.
    Wagemaker G, Vriesendorp HM, Van Bekkum DW (1981) Successful bone marrow transplantation across major histocompatibility barriers in rhesus monkeys. Transplan Proc 13: 875Google Scholar
  24. 24.
    Wagemaker G, Heidt PJ, Merchav S, Van Bekkum DW (1982) Abrogation of histocompatibility barriers to bone marrow transplantation in rhesus monkeys. In:Baum JS, Ledney GD, Thierfelder S (eds) Experimental hematology today. Karger, Basel, p 111Google Scholar
  25. 25.
    Walma EP, Wagemaker G (1981) Fractionated total body irradiation as conditioning for bone marrow transplantation in dogs and monkeys. Meeting of the Netherlands Radiobiological Society and Netherlands Society for Radiotherapy, Leiden, October 10. Int J Radiat Biol 41: 63 (abstr)Google Scholar
  26. 26.
    Walma EP, Vriesendorp HM, Zurcher C, Van Bekkum DW (1987) Engraftment of stem-cell-enriched bone marrow fractions in MHC-identical dogs after fractionated total-body irradiation. Transplantation 43: 818PubMedGoogle Scholar
  27. 27.
    Weiden PL, Flournoy N, Thomas ED (1979) Antileukemic effect of graft-versus-host disease in human recipients of allogeneic marrow grafts. N Engl J Med 300: 1068PubMedCrossRefGoogle Scholar
  28. 28.
    Yasumizu R, Sugiura K, Iwai H et al. (1987) Treatment of type 1 diabetes mellitus in non-obese diabetic mice by transplantation of allogeneic bone marrow and pancreatic tissue. Proc Natl Acad Sci USA 84: 6555–6557PubMedCrossRefGoogle Scholar
  29. 29.
    Knaan-Shanzer S, Houben PFJ, Kinwel-Bohré EPM, van Bekkum DW (1991) Remission induction of adjuvant arthritis in rats by total body irradiation and antologous bone marrow transplantation. Bone Marrow Transplant (to be published)Google Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1991

Authors and Affiliations

There are no affiliations available

Personalised recommendations